CK1 is also implicated in other neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease, as it can phosphorylate APP-β [168], tau [169–171], and α-synuclein [171, 172]. This evidence concerns the gene MAPT and Alzheimer disease.